Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations

Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations

Bibliographic Details
Main Authors:	Gomaraschi, Monica, Obici, Laura, Simonelli, Sara, Gregorini, Gina, Negrinelli, Alessandro, Merlini, Giampaolo, Franceschini, Guido, Calabresi, Laura
Format:	Online
Language:	English
Published:	Elsevier 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096778/

Similar Items

Protective Effects of HDL Against Ischemia/Reperfusion Injury
by: Gomaraschi, Monica, et al.
Published: (2016)

eNOS Activation by HDL Is Impaired in Genetic CETP Deficiency
by: Gomaraschi, Monica, et al.
Published: (2014)

Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia
by: Conca, Paola, et al.
Published: (2012)

Hepatic ACAT2 Knock Down Increases ABCA1 and Modifies HDL Metabolism in Mice
by: Pedrelli, Matteo, et al.
Published: (2014)

Human Apolipoprotein A-I Natural Variants: Molecular Mechanisms Underlying Amyloidogenic Propensity
by: Ramella, Nahuel A., et al.
Published: (2012)

Amyloidogenic variant of apolipoprotein A-I elicits cellular stress by attenuating the protective activity of angiogenin
by: Del Giudice, R, et al.
Published: (2014)

Amyloidogenic Propensity of a Natural Variant of Human Apolipoprotein A-I: Stability and Interaction with Ligands
by: Rosú, Silvana A., et al.
Published: (2015)

Diflunisal in late-onset FAP patients with moderate to severe neuropathy
by: Obici, Laura, et al.
Published: (2015)

Misdiagnoses of transthyretin amyloidosis: a clinical and electrodiagnostic study
by: Cortese, Andrea, et al.
Published: (2015)

Distant Homology Modeling of LCAT and Its Validation through In Silico Targeting and In Vitro and In Vivo Assays
by: Sensi, Cristina, et al.
Published: (2014)

Lipid-bound apolipoproteins in tyrosyl radical-oxidized HDL stabilize ABCA1 like lipid-free apolipoprotein A-I
by: Hossain, Mohammad A, et al.
Published: (2012)

Alkaptonuria is a novel human secondary amyloidogenic disease
by: Millucci, Lia, et al.
Published: (2012)

Amyloidogenic and non-amyloidogenic transthyretin variants interact differently with human cardiomyocytes: insights into early events of non-fibrillar tissue damage
by: Manral, Pallavi, et al.
Published: (2015)

Implication of Low HDL-c Levels in Patients with Average LDL-c Levels: A Focus on Oxidized LDL, Large HDL Subpopulation, and Adiponectin
by: Mascarenhas-Melo, Filipa, et al.
Published: (2013)

Misfolding of Amyloidogenic Proteins and Their Interactions with Membranes
by: Relini, Annalisa, et al.
Published: (2013)

Apolipoprotein A-II Influences Apolipoprotein E-Linked Cardiovascular Disease Risk in Women with High Levels of HDL Cholesterol and C-Reactive Protein
by: Corsetti, James P., et al.
Published: (2012)

Markers of Increased Cardiovascular Risk in Postmenopausal Women: Focus on Oxidized-LDL and HDL Subpopulations
by: Mascarenhas-Melo, Filipa, et al.
Published: (2013)

High-Density Lipoprotein (HDL) Particle Subpopulations in Heterozygous Cholesteryl Ester Transfer Protein (CETP) Deficiency: Maintenance of Antioxidative Activity
by: Chantepie, Sandrine, et al.
Published: (2012)

Markers of Systemic Inflammation and Apo-AI Containing HDL Subpopulations in Women with and without Diabetes
by: Russo, Giuseppina T., et al.
Published: (2014)

Exploiting heterogeneous features to improve in silico prediction of peptide status – amyloidogenic or non-amyloidogenic
by: Nair, Smitha Sunil Kumaran, et al.
Published: (2011)

Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro
by: Ozawa, Daisaku, et al.
Published: (2016)

New tools to diagnose and follow FAC patients: biomarkers
by: Merlini, Giampaolo
Published: (2015)

Lipoprotein Glomerulopathy Associated with a Mutation in Apolipoprotein E
by: Magistroni, Riccardo, et al.
Published: (2013)

Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence
by: Hermans, Michel P, et al.
Published: (2011)

Disturbance of HDL apolipoprotein AI metabolism in severe hyperlipidemic and lipodystrophic HIV patients on a protease inhibitor treatment
by: Ouguerram, Khadija, et al.
Published: (2010)

Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease
by: Jensen, Majken K., et al.
Published: (2012)

Cholesterol Determines and Limits rHDL Formation from Human Plasma Apolipoprotein A-II and Phospholipid Membranes
by: Bassett, G. Randall, et al.
Published: (2012)

The Impact of Lipoproteins on Wound Healing: Topical HDL Therapy Corrects Delayed Wound Healing in Apolipoprotein E Deficient Mice
by: Gordts, Stephanie C., et al.
Published: (2014)

Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I
by: De Souza, Juliana A, et al.
Published: (2010)

Increased apolipoprotein M induced by lack of scavenger receptor BI is not activated via HDL-mediated cholesterol uptake in hepatocytes
by: Yue-Hua Feng, et al.
Published: (2018-08-01)

Association between LDL-C, Non HDL-C, and Apolipoprotein B Levels with Coronary Plaque Regression
by: Masson, Walter, et al.
Published: (2015)

Targeted Intracellular Delivery of Resveratrol to Glioblastoma Cells Using Apolipoprotein E-Containing Reconstituted HDL as a Nanovehicle
by: Kim, Sea H., et al.
Published: (2015)

β-COP as a Component of Transport Vesicles for HDL Apolipoprotein-Mediated Cholesterol Exocytosis
by: Ma, Weilie, et al.
Published: (2016)

HDL Cholesterol Story Is Dead: Long Live HDL!
by: Simha, Vinaya, et al.
Published: (2016)

Prediction of Amyloidogenic and Disordered Regions in Protein Chains
by: Galzitskaya, Oxana V, et al.
Published: (2006)

AmylPepPred: Amyloidogenic Peptide Prediction tool
by: Nair, Smitha Sunil Kumaran, et al.
Published: (2012)

IgG Conformer's Binding to Amyloidogenic Aggregates
by: Phay, Monichan, et al.
Published: (2015)

Anti-Amyloidogenic Properties of Some Phenolic Compounds
by: Porzoor, Afsaneh, et al.
Published: (2015)

Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system
by: Nádia Pereira Gonçalves, et al.
Published: (2017-06-01)

Monitoring safety and effectiveness of Tafamidis in transthyretin amyloidosis in Italy: a 3-year longitudinal multicenter study in a non-endemic area
by: Cortese, Andrea, et al.
Published: (2015)